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Abstract
Variation in genetic background can significantly influence the phenotypic outcome of both disease and non-disease
associated traits. Additionally, differences in temporal and strain specific gene expression can also contribute to phenotypes
in the mammalian retina. This is the first report of microarray based cross-strain analysis of gene expression in the retina
investigating genetic background effects. Microarray analyses were performed on retinas from the following mouse strains:
C57BL6/J, AKR/J, CAST/EiJ, and NOD.NON-H2
-nb1 at embryonic day 18.5 (E18.5) and postnatal day 30.5 (P30.5). Over 3000
differentially expressed genes were identified between strains and developmental stages. Differential gene expression was
confirmed by qRT-PCR, Western blot, and immunohistochemistry. Three major gene networks were identified that function
to regulate retinal or photoreceptor development, visual perception, cellular transport, and signal transduction. Many of the
genes in these networks are implicated in retinal diseases such as bradyopsia, night-blindness, and cone-rod dystrophy. Our
analysis revealed strain specific variations in cone photoreceptor cell patterning and retinal function. This study highlights
the substantial impact of genetic background on both development and function of the retina and the level of gene
expression differences tolerated for normal retinal function. These strain specific genetic variations may also be present in
other tissues. In addition, this study will provide valuable insight for the development of more accurate models for human
retinal diseases.
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Introduction
The amount of genetic diversity within a species is significant and
contributes to the survival ofthe species throughgeneticdrift. There
are many examples of sequence variants which have no detrimental
functional consequences. These variants result in a range of normal
phenotypesaswellasthoseassociated withdisease.Forexample,iris
pigmentation is an easily observable trait that varies with genetic
background and has no detrimental consequence [1]. Other
observable phenotypic changes are non-disease associated, and
result in the biological diversity seen between individuals. These can
include alterations in skin pigmentation, hair pigmentation, height,
and other non-disease associated traits.
Genetic variation can also have a negative impact. Disease
associated phenotypic differences such as severity and progression
rate can be the result of single gene mutations and different
mutations within the same gene causing unique phenotypes [2]. In
addition, quantitative trait loci (QTL) and modifier genes are
examples of mechanisms where multiple sequence variants work in
concert to produce a single phenotype [3]. Thus, variations in
disease phenotype can vary not only between individuals, but also
within a given gene. There are many examples in humans of
variation in disease phenotype due to variation in genetic
background, including rheumatoid arthritis, coeliac disease, and
interstitial lung disease [4–5]. Genetic disorders can often exhibit
large variations in disease expressivity and penetrance that can be
attributed to allelic differences or genetic background effects. The
influence of genetic background on disease phenotype is commonly
observed in mice [6,7–11]. However, the underlying genetic
determinants responsible for many phenotypic variances are still
poorly understood.
There are over 200 inbred mouse strains, each with unique genetic
and phenotypic traits (http://jaxmice.jax.org/research/index.html).
Phenotypic variations in inbred mouse strains have served as models
for many human diseases, and are used in the development of new
therapies. Such diseases include obesity [12], seizure threshold [13],
alcoholconsumption [14], visual acuity [15], complete agenesis of the
corpus collosum [16], and aggressive behavior [17].
Genetic alterations have a significant impact on the retina. Over
two-thirds of retinal diseases result in degeneration of rod and/or
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e21858cone photoreceptor cells, which comprise 70% of all retinal cells.
Phenotypic variations in the retina include disease onset and
severity, such as that observed for the retinal degeneration 7 (rd7)
mouse model, which harbors a mutation in the nuclear hormone
receptor Nr2e3 [18] and models the human retinal disease
enchanced S-cone syndrome. The identification of underlying
genetic determinants and their associated pathways is thus vital to
further understanding the influence of genetic variation on
phenotypic variation and severity.
The inbred strains used in this study are homogenous within the
strain yet highly genetically divergent from one another [9]. Three
of the strains (CAST/EiJ, AKR/J, NOD.NON-H2
-nb1) are known
to harbor suppressor alleles for retinal degeneration associated
with the rd7 phenotype [6] while one strain, C57BL6/J (B6),
exhibits 100% penetrance for the disease. These strains have also
been shown to harbor modifier alleles for other phenotypes. For
example, the AKR/J mouse harbors modifier alleles for RS1
related X-Linked retinoschisis [19] and TUB related retinal
degeneration [20]. Similarly, the CAST/EiJ mouse harbors
modifier alleles for EYA1 related cochlear aplasia [21], Apc
(Min) related intestinal polyps [22], and can develop coloboma.
Additionally, micro- or anophthalmia is frequently observed in
C57BL6/J mice (our unpublished observations). These strains are
derived from both wild and inbred mice. The diverse genetic
backgrounds of the strains used, and the inclusion of strains not
noted for limited polymorphism ensures a more accurate analysis
of differential expression between strains [23].
The purpose of this study was to determine the impact of
differential gene expression, on the morphology and function of
the developing and mature mouse retina. The study was
performed using four genetically divergent inbred strains of mice
(C57BL6/J; AKR/J; CAST/EiJ; NOD.NON-H2
-nb1) that were
previously shown to harbor modifier alleles for retinal degener-
ation [18]. Each strain has a unique signature gene expression that
impacts whole gene networks temporally. These signature strain
specific differences translate into biological consequences affecting
cell patterning and retinal function. This study thus provides
valuable insight into the consequence of varying gene expression
on biological processes. These data will further aid in the
development of more appropriate mouse model systems that
recapitulate human disease, which may ultimately impact disease
causality and response to therapies.
Results
Microarray Expression Analysis and Confirmation
To determine the impact of genetic background on differential
gene expression, we performed microarray analysis on retinas
from C57BL6/J, CAST/EiJ, AKR/J, and NOD.NON-H2
-nb1
mice at E18.5 and P30.5. Expression variances were identified by
pair-wise comparisons of each strain relative to C57BL6/J utilizing
criteria of a 2 fold change or greater and a p-value ,0.001
adjusted for a false discovery rate of 10% (BRB Arraytools).
Significant strain specific variations in expression were identified at
both E18.5 and P30.5, clearly visible by heatmap (Figure 1).
Expression data was confirmed by qRT-PCR, with over 82% of
the 138 genes tested confirmed. Genes involved in retinal function,
such as the perception of external stimuli, retinoic acid receptor
activity, axon guidance, photoreception, and neuronal develop-
ment had a greater than 90% confirmation rate (Table 1). We also
found 3098 and 2685 differentially expressed genes to be highly
statistically significant at E18.5 and P30.5 respectively (Table S1).
A subset of the statistically significant genes (120) from the E18.5
dataset were selected for further analysis based on the following
criteria in addition to their initial statistical significance: 1) a
known role in retinal development; 2) an association with retinal
disease; 3) a wide disparity in inter-strain expression. Ontological
analysis was performed on these genes and generated three major
networks (Table 1). Additionally, we observed temporal variance
in gene expression across all strains.
To further determine strain specific and temporal gene
expression, clustering analysis using GeneCluster 2 was performed.
Multiple clusters containing highly significant genes were gener-
ated. These clusters were generated based on 1) statistical
significance of differential expression 2) expression unique to a
given strain (i.e. up-regulated in AKR/J); these clusters verified
our prior observation of strain specific and temporal gene
expression. These clusters were analyzed to determine their
involved pathways. AKR/J specific genes functioned in DNA
binding and transcription, cell cycle and phosphorylation; CAST/
EiJ specific genes functioned in apoptosis, protein localization,
synaptic transmission and cell morphogenesis; while genes specific
to E18.5 functioned cell cycle, phosphorylation, neurological
function, and apoptosis. A subset of these clusters featuring strong
strain specific expression at both E18.5 and P30.5 is shown
(Figure 2). These results further illustrate the impact of genetic
background on gene expression as well as temporal gene
expression during development.
Determination of Gene Ontologies and Functional
Relationships of Differentially Expressed Genes
Pathway analysis was performed to identify key gene networks
that were differentially expressed. Analysis of these differentially
expressed genes revealed conserved top scoring networks, network
functions, and canonical pathways relative to C57BL6/J. Specific
genes exhibiting the greatest variation differed between strains and
network involvement (Table S2). At P30.5, three major networks
were identified functioning in neurological disease, nervous system
development and function, and axonal guidance; while at E18.5
three networks were identified functioning in cell signaling, cellular
assembly and cellular organization. Interestingly, CAST/EiJ
showed the greatest expression variation (as great as 147 fold)
between strains, such as with its down regulation of Nyctalopin
(NYX) (24.42 fold, p,7.92x10
28).
Pathway analysis of the 120 gene subset was performed to
determine additional gene function. This analysis revealed
involvement in transcription, signal transduction, sensory percep-
tion, and cellular communication (Network 1); photoreception,
development, and metabolism (Network 2); and cell communica-
tion (Network 3). The genes within these networks varied in
individual function, but showed primary involvement in transcrip-
tion (41%), visual perception (13%), and signal transduction/cell
communication (6%). Each network showed strain specific
variation, while Networks 1 and 2 also showed temporal variation.
These networks show more specialized function in the retina
relative to the initial three networks. However, variation within
both networks suggests phenotypic consequences resulting from
expression variances are not limited to the retina.
Interestingly, genes showing both strain specific and temporal
variation include genes which have been implicated in retinoblas-
toma (RBL1; [24]), focal retinal ganglion cell loss (THRAP3; [25]),
and retinal development (NCOA2; [26], CRABP1 [27], RGS9 [28],
and TLE1 [29]). RGS9 for example, is associated with Bradyopsia
in humans [30], which is characterized by significant down
regulation in P30.5 CAST/EiJ (10.1 fold, p,2.276
1028), and
decreased electroretinogram amplitudes, correlates or mimics the
response suppression observed in affected humans.
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Analysis of networks based on genes involved in cell cycle, age
related macular degeneration (AMD), and development were also
performed showing temporal and strain specific variation in
expression. Rationale for the retinal disease pathway was based on
findings that genetic alterations specific to CAST/EiJ have been
shown to be potentially involved in the development of age related
macular degeneration (AMD) [31]. The AMD network was
generated utilizing several AMD associated genes [32–52]. The
cell cycle, AMD, and development pathways exhibited strain
specific variation in expression (Figure 3).
A developmental network (Figure 3) was also generated based
on NOTCH, WNT, and JAG which are known to be involved in
brain development [53], inner ear development [54], response to
Vitamin D [55], and retinal development [56,57]. This network
showed strain specific variation in expression as well as temporal
variances. These temporal expression variances are further
supported by current studies showing NOTCH and WNT temporal
expression is involved in retinal development [56,57].
Functional Correlation of Gene Expression with Observed
Phenotypes
Electroretinograms were performed to determine if genetic
background influences retinal function (Figure 4). Rod and cone
photoreceptor cell function are depicted by the amplitude and
temporal length of the a-wave and communication to second order
neurons by the b-wave. Each strain exhibited unique retinal
responses to light stimuli. Our previous report focused on cone
photoreceptor (photopic, light adapted) function and showed
CAST/EiJ retinas have reduced cone response compared to
NOD.NON-H2
-nb1 and C57BL6/J [9]. In this study, we examine
rod photoreceptor (scotopic, dark adapted) function. Overall,
C57BL6/J retinas showed the greatest amplitudes of scotopic a-
and b-waves while AKR/J retinas exhibit the smallest scotopic b-
wave response (Figure 4). These strain specific variations in retinal
response mimic human retinal disease. This similarity adds
support for these strains as models for human disease.
Variation in Genetic Background Influences Protein
Expression in the Retina
Western blot and immunohistochemical analysis was performed
on five confirmed differentially expressed genes to determine if
differences in mRNA expression impact protein expression and
(Figure 5). These genes were selected based on their involvement
in our first top scoring gene network. This network features genes
present in the TRb pathway. Pathway analysis of TRb shows
interaction with OPN1SW. Genes with tested antibodies were used
for western blotting and immunohistochemistry. The majority of
genes examined exhibited differential protein expression consistent
with differential transcript expression. Localization of PRPF3,
NCOA2, MED1, and THRAP3 protein was consistent between
strains while localization of FOXC1 varied.
Strain Specific Variations of Cone Cell Topography,
OPN1SW Distribution, and Cone Specific Genes
Blue opsin expression occurs in a dorsal-ventral gradient
distribution in the mouse retina [58], with approximately one
third of the retina showing littleo rn ob l u eo p s i ne x p r e s s i o n .T o
determine if retinal topography varies between strains, we
examined whole mounts of P30.5 retinas from each strain
labeled with peanut lechtin (PNA) to label all cones, and blue
opsin (OPN1SW) to label blue cones. Total cone and blue opsin
expressing cone cell abundance was measured within central,
dorsal, and ventral retina in a 500 um region (Figure 6;
Figure 7).
Total cell quantification showed C57BL6/J to have the greatest
abundance of cone cells. Between the other strains, CAST/EiJ
exhibited the greatest number of dorsal cone photoreceptor cells,
the fewest ventral, and the fewest cone photoreceptor cells overall.
Similarly, AKR/J had the fewest dorsal cone photoreceptor cells,
but the greatest ventral. Additionally, NOD.NON-H2
-nb1 had the
greatest overall cone cell abundance. For blue opsin expressing
cone cells, C57BL6/J also showed the greatest abundance.
Between other strains, CAST/EiJ retinas showed the fewest
number in both the dorsal and ventral retina, AKR/J the greatest
dorsal number, and NOD.NON-H2
-nb1 the greatest ventral
number. This critical finding suggests that high abundance of
cone cells does not imply a high expression of blue opsin. This
confirms our previous finding that total cone cell abundance does
not imply high abundance within a specific retinal region.
Interestingly the expression levels of several cone cell specific
genes [59] correlate with total and blue opsin expressing cone cell
abundance. C57BL6/J showed the highest expression of all cone
specific genes (Figure S1).
Discussion
Genetic background can have a profound impact on both
disease and non-disease associated phenotypes. We determined
that genetic background impacts whole gene networks, key
developmental processes that establish normal retinal topography,
and ultimately influences phenotypic outcome associated with
human retinal disease. These findings have wide reaching impacts
as they each substantiate the fact that genetic background can not
only influence disease phenotypes, but that non-diseased, ‘‘nor-
mal’’ phenotypes can show variations as a function of genetic
background as well. Signature expression profiles identified three
major biological networks and several tangent networks. The
influence of genetic background on the expression of these
networks shows strain and temporal specific variation. Putative
network function analyses suggest that genetic background
influences biological processes affecting cell signaling and cellular
organization.
In this study, we determined a key correlation between retinal
topography and genetic background. In the mammalian retina,
cone photoreceptor cells are distributed in a defined pattern
across the retina. In humans and non-human primates, there is a
macula near the center of the eye. Within the macula is the fovea,
a cone dense region comprised solely of red and green cones.
This region of the eye provides the highest point of visual acuity.
Genetic defects affecting the macula include cone dystrophies and
macular degeneration, and affect the central vision. Humans and
non-human primates possess a single fovea while bird species
such as hawks are bifoveal, and dogs and cats lack a fovea but
have a central band known as a visual streak (http://www.
Figure 1. Heatmap of Gene Expression in CAST/EiJ; C57BL6/J; AKR/J; and NOD.NON-H2-nb1. Color key represents the relative expression
for a gene for each strain based on the estimated mean log2 intensities. Rows represent the individual genes, while columns represent each strain.
Top heat map depicts expression and average-linkage hierarchical clustering for differentially expressed genes at P30.5 from each pair comparison
relative to B6. Bottom heat map depicts expression and average-linkage hierarchical clustering for differentially expressed genes at E18.5 from each
pair comparison relative to B6.
doi:10.1371/journal.pone.0021858.g001
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Gene Strain Timepoint Microarray Fold Change qRT-PCR Fold Change
Transcription/Signal Transduction Network
(Network 1) Foxc1 AKR/J E18.5 10.02 17.45
Rarg AKR/J E18.5 2.61 12.00
Gng2 CAST/EIJ E18.5 211.11 21.31
Ncoa2 CAST/EIJ E18.5 1.29 1.69
Nrip1 CAST/EIJ E18.5 22.78 21.69
Rarb CAST/EIJ E18.5 2.56 1.71
Rbl1 CAST/EIJ E18.5 25.00 21.86
Sfrp1 CAST/EIJ E18.5 3.69 3.65
Cd151 CAST/EIJ P30.5 2.74 21.19
Itgb5 CAST/EIJ P30.5 211.11 254.33
Kif4 CAST/EIJ P30.5 21.18 23.09
Med1 CAST/EIJ P30.5 24.17 22.87
Nfatc2 CAST/EIJ P30.5 2.07 1.53
Nr2c1 CAST/EIJ P30.5 22.38 23.06
Nr2c2 CAST/EIJ P30.5 21.72 21.70
Opn1sw CAST/EIJ P30.5 21.67 1.14
Prrx1 CAST/EIJ P30.5 21.39 22.05
Thrap3 CAST/EIJ P30.5 212.50 23.23
Tle4 CAST/EIJ P30.5 3.20 21.59
Nsd1 NOD.NON-H2-nb1 E18.5 21.89 21.91
Sema3b NOD.NON-H2-nb1 E18.5 1.25 1.03
Photoreception/Development Network
(Network 2) Nisch CAST/EIJ E18.5 216.67 24.37
Rai14 CAST/EIJ E18.5 25.26 22.94
Retsat CAST/EIJ E18.5 6.18 1.17
Rpgrip1 CAST/EIJ E18.5 24.00 24.73
Trp53bp1 CAST/EIJ E18.5 220.00 21.63
Crabp1 CAST/EIJ P30.5 2.45 1.48
Rab21 CAST/EIJ P30.5 2.51 21.28
Rab37 CAST/EIJ P30.5 21.11 21.25
Rgs9 CAST/EIJ P30.5 210.00 21.79
Scmh1 CAST/EIJ P30.5 22.08 24.33
Tle1 CAST/EIJ P30.5 2.13 21.24
Vsx1 CAST/EIJ P30.5 21.10 225.43
Mitf NOD.NON-H2-nb1 E18.5 2.84 4.51
Cell Communication Network
(Network 3) Crxos1 AKR/J E18.5 22.00 210.98
Jag1 CAST/EIJ E18.5 3.03 2.03
Abcd2 CAST/EIJ P30.5 21.16 223.11
Fbxo2 CAST/EIJ P30.5 1.21 22.71
Fbxo9 CAST/EIJ P30.5 1.98 21.27
Rorb CAST/EIJ P30.5 1.34 22.53
Spata5l1 CAST/EIJ P30.5 23.85 21.38
Zfp365 CAST/EIJ P30.5 2.55 1.47
Sema3c NOD.NON-H2-nb1 E18.5 4.32 5.81
Rbp3 NOD.NON-H2-nb1 E18.5 23.03 23.91
Sox30 NOD.NON-H2-nb1 P30.5 10.57 65.83
Genes found statistically significant by microarray that were tested via qRT-PCR. Fold changes found by microarray and qRT-PCR are shown, as well as strain and time
point in which the gene was tested.
doi:10.1371/journal.pone.0021858.t001
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a macula or fovea proper, however there is gradient in expression
of the opsin genes in mouse cone cells. Green opsin has a uniform
pattern of expression while blue opsin is expressed in a dorsal to
ventral gradient, with a ventral concentration [58]. In this study,
we determined that while the general pattern of cone photore-
ceptor cells and blue opsin expression is conserved, there are
pronounced differences in patterning between mouse strains.
Using these ‘‘normal’’ inbred strains, our findings illustrate that
genetic background has profound effects on normal cell
patterning in the retina. This observation is seen in other eye
phenotypes in humans, such as variations in iris pigmentation,
corneal thickness, and intra-ocular pressure. These studies thus
illustrate the tolerance of the system to impact normal retinal
morphology.
The observed changes in retinal function between strains and
their correlation with gene expression show that strain specific
variations may increase the susceptibility to disease for that strain.
Additionally, the variations in expression between strains that
show no association with disease illustrate the principle that
normal variation between strains exist which are not associated
with disease phenotypes. These variations between strains allow
their use as models for human ocular diseases while further
modeling normal variation between individuals. For example,
CAST/EiJ mice exhibit decreased rod function correlating with
significantly diminished expression of NYCTALOPIN (NYX) which
models human retinal disease as human mutations in NYCTALO-
PIN are associated with phenotypes associated with impaired rod
function, decreased a-wave amplitude, X-linked retinoschisis, and
X-linked congenital stationary night blindness [60-62]. CAST/EiJ
also shows differential expression of RGS9; FOXC1; RPGRIP1;
VSX1; RARB; and NSD1. Mutations within these genes have been
associated with Bradyopsia; iris hypoplasia with glaucoma [63];
cone-rod dystrophy 13 [64]; corneal dystrophy [65]; Waardenburg
syndrome [66]; and Sotos syndrome [67] respectively. We
observed significant down-regulation of RBP3 in NOD.NON-
H2
-nb1 (-7.9 fold, p,3.2610
29), a gene in which mutations have
been associated with autosomal recessive retinitis pigmentosa [68].
We further observed two known retinal genes [69,70] ROBO2 and
TRPM3, to be significantly down regulated in CAST/EiJ and
NOD.NON-H2
-nb1 respectively; while also identifying multiple
novel genes within our pathways that may be associated with the
observed changes in retinal function.
Taken together, the genomic, structural, and functional
correlations illustrate the variability tolerated and the level of
what is considered ‘‘normal’’. These studies demonstrate the
strong influence of genetic background on phenotypic outcome.
The inbred mouse strains, while providing a uniform genetic
background are present with unique signature gene expression
profiles. These unique gene network/pathway profiles must be
taken into consideration when using these to generate targeted
genetically engineered animals. Further, by identifying key
pathways associated with disease, while accurately noting benign
genetic variants, a more targeted approach to understanding
disease pathology and future targeted gene therapy design can be
achieved.
Methods
Ethics Statement
All animals were bred and maintained under standard
conditions at The University of Nebraska Medical Center research
vivarium in accordance with protocol #04086, approved by the
Animal Care and Use Committee at the University of Nebraska
Medical Center. Mice were housed in microisolator cages and
provided food and water ad libitum. The University of Nebraska
Medical Center is in compliance with the NIH policy on the use of
animals in research (Animal Welfare Act P.L. 89–544, as amended
by P.L. 91–579 and P.L. 94–279) as well as the Guide for the Care
and Use of Laboratory Animals, NIH Publication No. 86–23.
Mice used in this study were bred and maintained under
standard conditions in the research vivarium at the University of
Nebraska Medical Center. Tissues were harvested from four
genetically divergent strains of mice: B6 (C57 derived strain),
CAST/EiJ (wild derived strain), AKR/J (derived from Castle’s
mice), and NOD.NON-H2
-nb1 (derived from Swiss mice) [71].
Retinal tissue was collected at embryonic day 18 (E18.5) and
postnatal day 30 (P30.5). Adult mice were examined clinically by
indirect ophthalmoscopy to examine the fundus.
Figure 2. Cluster Based Analysis of Strain Specific and
Temporal Gene Expression. Cluster based analysis showing
significant strain specific gene expression at E18.5 and P30.5. X axis
designates strain/time while the Y axis depicts standardized mean log2
intensity. The number in each cluster graph is the number of genes
within each cluster.
doi:10.1371/journal.pone.0021858.g002
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PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e21858Figure 3. Key Pathway Analyses of Cell Cycle; AMD; and Development. Gene expression levels for genes present in the cell cycle, age related
macular degeneration, and development pathways at E18.5 and P30.5 are shown. Expression levels for each strain are relative to C57BL6/J.
doi:10.1371/journal.pone.0021858.g003
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All microarray data from this study has been made MIAME
complaint and is publicly available through the Gene Expression
Omnibus (GEO) database under the series record GSE24512.
Microarray Analysis
RNA was isolated at E18.5 and P30.5 as previously described
[72]. Briefly, eyes were enucleated and placed in PBS on ice.
Retinas were dissected using a stereo microscope (Zeiss Stemi SV
11) and RNA was isolated by TRIzol
H extraction. A total of 30
retinas were collected from 15 mice of each strain at similar time
points during the day. Equimolar amounts of RNA isolated from
ten retinas were pooled into three separate pools from each strain
and time point. RNA was hybridized to Mouse 420A 2.0
(Affymetrix, Santa Clara, CA) chips by the UNMC Microarray
Core Facility according to manufacturer specifications (Affymetrix,
Santa Clara, CA). Data quality was assessed using the affyPLM
package for the R programming language. Consistency of
expression levels was confirmed by validation across multiple
redundant probe sets. Differential expression analysis was
performed using the Linear Models for Microarray Analysis
portion of Bioconductor. Genes found to be differentially
expressed for each pair wise comparison using a FDR-adjusted
p-value of 0.001 and at least a 2 fold change were combined and
used to perform clustering analysis. A self-organizing map (SOM)
clustering algorithm was applied to genes showing significant
expression differences as judged by mean log2 intensity per strain.
The gap statistic was used to estimate the optimal number of
clusters. Additional analysis was performed using BRB Array
Tools for Excel 2007, as well as the Stanford Statistical Analysis of
Microarrays (SAM) plug-in for Excel 2007. Subsequent pathway
analysis based on genes found to be statistically significant by these
methods was performed using Ingenuity Pathway Analysis
software. Gene ontology and further annotation of genes was
performed using the Affymetrix NetAffx database, BRB Array
Tools, the Database for Annotation, Visualization, and Integrated
Discovery (DAVID) (http://david.abcc.ncifcrf.gov), and the
UCSC Genome Browser. Specific fold changes for each gene
within each network, including fold changes across multiple probes
is available for all strains and time points for both the 3098 gene
derived networks (Table S3) and the 120 gene derived networks
(Table S4).
Quantitative RT-PCR
Real-time qRT-PCR was performed as previously described [72]
to confirm differential expression observed in the microarray data.
Greater than 82% of significant gene expression differences were
confirmed by quantitative real time-PCR (qRT-PCR)with 45 of the
138 genes tested belonging to top scoring networks. RNA was
isolated using the pooled samples from the microarray analysis as
well as additional individual samples from E18.5 and P30.5 mice for
each strain. First strand synthesis was performed using the
RETROscript (Ambion, Austin, TX) on 2 mg of RNA template.
Primers were selected using Primer3 software (Table S5). RNA and
primers were diluted to 1:100 concentrations prior to amplification,
with qRT-PCR performed utilizing SYBR green PCR master mix
(Applied Biosystems, Foster City, CA). qRT-PCR was performed
on an ABI 7500 using default cycling parameters. For each RNA
sample, triplicate reactions were performed, averaged, and DCt
normalized to b-actin. Comparisons between strains were made for
Figure 4. Scotopic Electroretinogram Analysis. ERG analysis is
shown for each strain under scotopic conditions. Each strain represents
the average of readings for three animals. Amplitude is measured in
micro-volts (u) while time is measures in milliseconds (ms) with error
bars shown for the A and B-waves respectively.
doi:10.1371/journal.pone.0021858.g004
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using the following formula: 1000/2
DCtbactin-DCttestgene. Statistical
significance of differential expression was determined by T-test
using a p-value of ,0.05.
Immunofluorescence
Histological samples were prepared as previously described
[73]. Briefly, animals were euthanized and eyes were oriented
dorsal to ventral with a cautery, and subsequently fixed in 4%
paraformaldehyde or 3:1 methanol:acetic acid overnight at 4uC.
Tissues were paraffin embedded and sectioned at 5 mm.
Immunohistochemistry was performed as previously described
[73]. Whole mounts of the retina were prepared for immunohis-
tochemistry as described: Retinas were dissected and incubated
for 15 min in cold buffer (50 mM NH4Cl, 0.02% sodium azide
(NaN3 in PBS) twice and blocked overnight (0.01% Triton X100,
Figure 5. Western Blot and Immunohistochemical Analysis of Protein Expression and Localization. Western blots and
immunohistochemical staining of retinal cross sections using antibodies FOXC1, PRPF3, NCOA2, MED1, and THRAP3. Each was found to be
differentially expressed at the transcript level by microarray and qRT-PCR. Western Blot expression levels are in reference to levels of beta-actin. Cross
sections used for immunohistochemistry are matched for orientation and field of view. Cross sections of E18.5 retinas are labeled with the following:
retinal pigment epithelium (RPE), outer neuroblastic layer (ONBL), and inner neuroblastic layer (INBL). Cross sections of P30.5 retinas are labeled with
the following: retinal pigment epithelium (RPE), outer segment (OS), outer nuclear layer (ONL), inner nuclear layer (INL), and ganglion cell layer (GCL).
doi:10.1371/journal.pone.0021858.g005
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antibody in blocking solution overnight at room temperature
with gentle agitation. Retinas were then washed six times, 30 min
each in blocking solution and incubated overnight in secondary
antibody in blocking solution at room temperature. Retinas were
rinsed six times, 30 min each at room temperature and mounted
using SlowFade Light Antifade kit (Molecular Probes). The
following primary antibodies were used at 1:200 dilutions for
immunohistochemistry, both sections and whole mounts:
OPN1SW (goat polyclonal, SC-14363 Santa Cruz), Red/Green
Opsin AB5405 (Millipore). The following secondary antibodies
were used at 1:400 dilutions for immunohistochemistry, both
sections and whole mounts: Alexa Fluor 488 (Goat anti-rabbit,
Invitrogen), Alexa Fluor 555 (rabbit anti-goat, Invitrogen).
Western Blot Analysis
Western blot analysis was performed as previously described
[18]. Briefly, retinas were homogenized in RIPA buffer (1 x TBS,
1% Igepal, 0.5% Na.Deoxycholate, 0.1% SDS, 0.04% Na.Azide,
1 mm PMSF), with 40 ug of protein utilized for each western blot.
Primary antibodies used at 1:500 dilutions unless otherwise
indicated: PRPF3 (rabbit polyclonal, Aviva); THRAP3 (rabbit
polyclonal, Lifespan); MED1 (rabbit polyclonal, AbCam); CERKL
(rabbit polyclonal, AbCam); NRIP1 (RIP140) (1:1000, rabbit
polyclonal, AbCam); NCOA2 (1:1000, rabbit polyclonal, AbCam);
FOXC1 (1:1000, goat polyclonal, AbCam); and IRBP (1:200, goat
polyclonal, Santa Cruz). The following secondary antibodies were
used at 1:10,000 dilutions: Alexa Fluor 488 (anti-rabbit, Invitro-
gen), Alexa Fluor 555 (anti-goat, Invitrogen), and Alexa Fluor 488
Figure 6. Cone Cell and OPN1SW Expressing Cone Cell Abundance across Strains. Cone cell counts within the central retina, dorsal and
ventral retina, and those for dorsal and ventral cone cells expressing blue opsin are shown for each strain.
doi:10.1371/journal.pone.0021858.g006
Figure 7. Retinal Whole Mounts Labeling OPN1SW for NOD.NON-H2-nb1; AKR/J; C57BL6/J; and CAST/EiJ. Immunohistochemical
analysis of retinal whole mounts for each strain labeling blue opsin (OPN1SW). Whole mounts are orientation matched, with dorsal and ventral being
labeled.
doi:10.1371/journal.pone.0021858.g007
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10% Tris-Bis NuPage gels (Invitrogen) according to manufactur-
er’s recommendations. Proteins were transferred onto PVDF
membranes and western blot analysis was performed using the
Odyssey Infrared Imaging System (LiCor Technologies) according
to manufacturer’s recommendations. Blots were incubated in
Odyssey blocking solution for 1 hour at room temperature. All
primary antibodies were incubated in Odyssey blocking solution
overnight at 4uC while secondary antibodies were incubated for
1 hour at room temperature. Images were visualized using
Odyssey system and Odyssey v.1.2 software.
Electroretinography
Electroretinogram analysis was performed on 7 mice of each
strain (1–3 months). Mice were anesthetized with an intraperito-
neal injection of a saline carrier (10 mg/g body weight) containing
ketamine (1 mg/mL) and xylazine (0.4 mg/mL). Dark adapted
(scotopic) electroretinogram recordings were performed using the
UTAS E4000 system (LKC Technologies INC, Gaithersburg,
MD) as described previously [18]. Mice were dark adapted for at
least six hours and then anesthetized prior to recording. Signal
processing was performed using EM for Windows v7.1.2. Signals
were sampled every 0.8 ms over a response window of 200 ms. For
each stimulus condition, responses were computer averaged with
up to 50 records for the weakest signals.
Pathway Generation and Analysis
Data were analyzed using Ingenuity Pathway Analysis (Inge-
nuity Systems, www.ingenuity.com). Gene identifiers and statisti-
cally significant expression values were uploaded into Ingenuity.
Default cutoffs were set to identify genes whose expression was
significantly differentially regulated and overlaid onto a global
molecular network developed from information contained in the
Ingenuity Pathways Knowledge Base. Networks were algorithmi-
cally generated based on their connectivity. Genes or gene
products in the networks are represented as nodes, and the
biological relationship between two nodes is represented as an
edge (line). All edges are supported by at least 1 reference from the
literature, from a textbook, or from canonical information stored
in the Ingenuity Pathways Knowledge Base. Nodes are displayed
using various shapes that represent the functional class of the gene
product.
Supporting Information
Figure S1 Cone Specific Gene Expression. Expression
levels for multiple genes specific in their expression to cone
photoreceptor cells are shown, as well as their chromosomal
locations within both human and mouse. Expression levels are
shown for each strain, relative to C57BL6/J, at both E18.5 and
P30.5.
(TIF)
Table S1 Standardized Microarray Expression Data
Averaged by Strain. Standardized microarray expression data
is shown for both E18.5 and P30.5 time points with expression
values averaged by strain.
(XLS)
Table S2 Genes Showing Greatest Variation within
Strains. Genes exhibiting the greatest fold changes for each
strain, at both E18.5 and P30.5 time points are shown. Gene
symbols, corresponding GeneIDs, and p-values for each fold
change are shown.
(TIF)
Table S3 Microarray Data for Probes Correlating to
Top Scoring Gene Networks. Microarray data is shown in
fold change (relative to C57BL6/J) for each strain at both E18.5
and P30.5 time points for each of the three top scoring 3098 gene
derived networks.
(XLS)
Table S4 Microarray Data for Probes Correlating to
120 Gene Networks. Microarray data is shown in fold change
(relative to C57BL6/J) for each strain at both E18.5 and P30.5
time points for each of the three top scoring 120 gene derived
networks.
(XLS)
Table S5 qRT-PCR Primer Design. Gene names, abbrevi-
ations, amplicon size, and forward/reverse primers are shown for
each primer pair used in qRT-PCR.
(PDF)
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